Simultaneous blockade of α1- and β-actions of epinephrine during cardiopulmonary resuscitation

Critical Care Medicine

Volumn 34, Issue 12 SUPPL., 2006, Pages

  Huang, Lei ^a   Sun, Shije ^a,b   Fang, Xiangshao ^a   Tang, Wanchun ^a,b   Weil, Max Harry ^a,b  

^a INSTITUTE OF CRITICAL CARE MEDICINE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cardiac arrest; Cardiopulmonary resuscitation; Epinephrine; Murine; Nonselective adrenergic blocker; Porcine; Postresuscitation myocardial dysfunction; Selective 1 adrenergic blocker; Survival

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADRENALIN; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; CORBADRINE; ESMOLOL; METHOXAMINE; OXYGEN; PHENYLEPHRINE; PLACEBO; PROPRANOLOL; YOHIMBINE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR;

ADRENERGIC ACTIVITY; ALPHA ADRENERGIC RECEPTOR BLOCKING; BETA ADRENERGIC RECEPTOR BLOCKING; CARDIOVERSION; CONFERENCE PAPER; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CONSTRICTION; DEFIBRILLATION; DISEASE SEVERITY; DOG; DRUG EFFECT; EXPERIMENTAL ANIMAL; EXPERIMENTAL MODEL; EXPERIMENTAL RAT; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; HEART PROTECTION; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; HUMAN; LACTATE BLOOD LEVEL; MYOCARDIAL DISEASE; NERVOUS SYSTEM FUNCTION; NONHUMAN; PRIORITY JOURNAL; RESUSCITATION; SURVIVAL TIME; SWINE; ANIMAL; DRUG ANTAGONISM; DRUG POTENTIATION; HEART ARREST; PATHOPHYSIOLOGY; REVIEW;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CARDIOPULMONARY RESUSCITATION; EPINEPHRINE; HEART ARREST; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, ADRENERGIC, ALPHA-2; VENTRICULAR FIBRILLATION;

EID: 33751117472     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000247724.19004.EB     Document Type: Conference Paper

References (23)

1. Standards and guidelines for cardiopulmonary resuscitation (CPR) and emergency care (ECC). JAMA 1974; 227(Suppl):833-868
2. Standards and guidelines for cardiopulmonary resuscitation (CPR) and emergency care (ECC). JAMA 1983; 240:453-509
3. Standards and guidelines for cardiopulmonary resuscitation (CPR) and emergency care (ECC). JAMA 1986; 255:2905-2989
4. Michael JR, Guerci AD, Koehler RC, et al: Mechanisms by which epinephrine augments cerebral and myocardial perfusion during cardiopulmonary resuscitation in dogs. Circulation 1984; 69:822-835
5. Nieman JT, Haynes KS, Garner D, et al: Post-countershock pulseless rhythms: Response to CPR, artificial cardiac pacing, and adrenergic agonists. Ann Emerg Med 1986; 15:112-120
6. Tang W, Weil MH, Gazmuri R, et al: Pulmonary ventilation/perfusion defects induced by epinephrine during CPR. Circulation 1991; 84:2101-2107
7. Redding JS, Pearson JW: The role of epinephrine in cardiac resuscitation. Anesth Analg 1963; 42:599-606
8. Ditchey RV, Rubio-Perez A, Slinker BK: Beta-adrenergic blockade reduces myocardial injury during experimental cardiopulmonary resuscitation. J Am Coll Cardiol 1994; 24:804-812
9. Ditchey RV, Slinker BK: Phenylephrine plus propranolol improves the balance between myocardial oxygen supply and demand during experimental cardiopulmonary resuscitation. Am Heart J 1994; 127:324-330
10. Wright M, Heath RB, Wingfield WE: Effects of xylazine and ketamine on epinephrine-induced arrhythmia in the dogs. Vet Surg 1986; 16:398-403
11. Tang W, Weil MH, Sun SJ, et al: Epinephrine increases the severity of postresuscitation myocardial dysfunction. Circulation 1995; 92:3089-3093
12. Ditchey RV, Lindenfeld J: Failure of epinephrine to improve the balance between myocardial oxygen supply and demand during closed-chest resuscitation in dogs. Circulation 1988; 78:382-389
13. Elizur A, Ben-Abraham R, Manisterski Y, et al: Tracheal epinephrine or norepinephrine preceded by beta blockade in a dog model: Can beta blockade bestow any benefits? Resuscitation 2003; 59:271-276
14. Grupp IL, Lorenz JN, Walsh RA, et al: Overexpression of alpha 1B-adrenergic receptor induces left ventricular dysfunction in the absence of hypertrophy. Am J Physiol 1998; 275:H1338-H1350
15. Landzerg JS, Parker JD, Gauhier DF, et al: Effects of myocardial α1-adrenergic receptor stimulation and blockade on contractility in humans. Circulation 1991; 84:1608-1614
16. 1-adrenergic tone does not influence the transmural distribution of myocardial blood flow during exercise in dogs with pressure afterload left ventricular hypertrophy. Basic Res Cardiol 1995; 90:73-83
17. 2-adrenergic coronary vasoconstriction during exercise in the ischemic heart. Circ Res 1997; 80:196-207
18. Lefkowitz RJ: Neurotransmission of the autonomic and somatic motor nervous system. In: Goodman and Gilman's: The Pharmacologic Basis of Therapeutics. Ninth Edition. Hardman LG, Limbird LE (Eds). New York, McGraw-Hill, 1996, p 137
19. Gregorini L, Marco J, Kozakova M, et al: Alpha-adrenergic blockade improves recovery of myocardial perfusion and function after coronary stenting in patients with acute myocardial infarction. Circulation 1999; 99:482-490
20. 2-adrenergic agonist for cardiac resuscitation. J Am Coll Cardiol 2001; 37:951-956
21. Klouche K, Weil MH, Tang W, et al: A selective α2-adrenergic agonist for cardiac resuscitation. J Lab Clin Med 2002; 140:27-34
22. 2-selective vasopressor agent for cardiopulmonary resuscitation. Circulation 2003; 108:2716-2721
23. Huang L, Weil MH, Sun S, et al: Carvedilol mitigates adverse effects of epinephrine during cardiopulmonary resuscitation. J Cardiovasc Pharmacol Ther 2005; 10:113-120